Estimation of Drug-Target Residence Times by τ‑Random
Acceleration Molecular Dynamics Simulations
Version 3 2018-06-04, 13:03Version 3 2018-06-04, 13:03
Version 2 2018-06-01, 20:15Version 2 2018-06-01, 20:15
Version 1 2018-05-31, 13:19Version 1 2018-05-31, 13:19
Posted on 2018-06-04 - 13:03
Drug-target
residence
time (τ), one of the main determinants
of drug efficacy, remains highly challenging to predict computationally
and, therefore, is usually not considered in the early stages of drug
design. Here, we present an efficient computational method, τ-random
acceleration molecular dynamics (τRAMD), for the ranking of
drug candidates by their residence time and obtaining insights into
ligand-target dissociation mechanisms. We assessed τRAMD on
a data set of 70 diverse drug-like ligands of the N-terminal domain
of HSP90α, a pharmaceutically important target with a highly
flexible binding site, obtaining computed relative residence times
with an accuracy of about 2.3τ for 78% of the compounds and
less than 2.0τ within congeneric series. Analysis of dissociation
trajectories reveals features that affect ligand unbinding rates,
including transient polar interactions and steric hindrance. These
results suggest that τRAMD will be widely applicable as a computationally
efficient aid to improving drug residence times during lead optimization.
CITE THIS COLLECTION
DataCite
DataCiteDataCite
No result found
Kokh, Daria B.; Amaral, Marta; Bomke, Joerg; Grädler, Ulrich; Musil, Djordje; Buchstaller, Hans-Peter; et al. (2018). Estimation of Drug-Target Residence Times by τ‑Random
Acceleration Molecular Dynamics Simulations. ACS Publications. Collection. https://doi.org/10.1021/acs.jctc.8b00230